#mdma

#mdma

FDA rejected MDMA for PTSD therapy due to insufficient data, raising doubts about psychedelics' future in U.S. medical system.

Studying mind-altering drugs like psychedelics faces challenges due to inability to blind participants, potentially impacting research validity.

Proper funding needed for integrated mental health care. MDMA and psychedelics show promise in psychiatric medicines based on evidence and controlled trials.

Drug potency at Electric Picnic poses serious health risks, with MDMA linked to medical emergencies. Seek help if feeling unwell after use.

Lee Gannon paid €300 to avoid a charge for possessing Ecstasy at a festival.

Gwyneth Paltrow's use of MDMA facilitated a significant improvement in her relationship with her mother.

Pharmaceutical companies are developing next-generation psychedelics to serve as safer psychotherapy treatments, with promising early research on compounds like R-MDMA.

Psychedelic drug MDMA's potential as PTSD treatment raises safety concerns

The FDA did not approve MDMA for PTSD therapy, requiring an additional clinical trial.

FDA's proposed restrictions on MDMA for PTSD patients include monitoring safeguards and restricted administration at healthcare facilities.

The FDA's rejection of MDMA-assisted therapy for PTSD was a significant setback for MAPS and the psychedelic research community.

MDMA-assisted psychotherapy is a promising treatment for PTSD and complex trauma, showing high efficacy and low dropout rates.

U.S. regulators may approve MDMA (ecstasy) for PTSD treatment, a first in over two decades.